Biotech · Private company
PhenoNet, Inc.
Track this companyFree. Adds PhenoNet, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Cromolyn Sodium (17.1 mg BID)Phase 2 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
- Cromolyn Sodium (34.2 mg BID)Phase 2 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
- Riluzole (100 mg)Phase 2 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPHASE2 · RECRUITING · started Nov 25, 2025ClinicalTrials.gov NCT07142291 · fetched Nov 12, 2026